We are live on ! Find out more
OI

Oakbrook Investments Portfolio holdings

AUM $39.2M
1-Year Est. Return 3.66%
This Fund
S&P 500
This Quarter Est. Return
+8.78%
1 Year Est. Return
-3.66%
3 Year Est. Return
+26.09%
5 Year Est. Return
+53.43%
10 Year Est. Return
AUM
$1.8B
AUM Growth
+$220M
Cap. Flow
+$92.2M
Cap. Flow %
5.11%
Top 10 Hldgs %
23.35%
Holding
698
New
144
Increased
374
Reduced
112
Closed
60

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$23.4M
2
V icon
Visa
V
+$13.3M
3
ADSK icon
Autodesk
ADSK
+$10.2M
4
PEP icon
PepsiCo
PEP
+$9.62M
5
ORCL icon
Oracle
ORCL
+$6.9M

Sector Composition

Rank Sector Weight
1 Technology 16.28%
2 Healthcare 15.36%
3 Financials 15.12%
4 Consumer Discretionary 11.34%
5 Industrials 11.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADM icon
101
Archer Daniels Midland
ADM
$37.4B
$3.02M 0.17%
60,110
+13,900
+30% +$682K
MET icon
102
MetLife
MET
$63.7B
$3M 0.17%
64,120
-7,680
-11% -$351K
TT icon
103
Trane Technologies
TT
$105B
$2.97M 0.16%
29,015
+7,950
+38% +$777K
AMD icon
104
Advanced Micro Devices
AMD
$799B
$2.96M 0.16%
95,810
+20,150
+27% +$455K
ICE icon
105
Intercontinental Exchange
ICE
$84.1B
$2.82M 0.16%
37,665
-4,000
-10% -$301K
PRU icon
106
Prudential Financial
PRU
$41.9B
$2.82M 0.16%
27,805
+11,645
+72% +$1.15M
WM icon
107
Waste Management
WM
$91.5B
$2.81M 0.16%
31,075
-100
-0.3% -$8.87K
NEE icon
108
NextEra Energy
NEE
$176B
$2.8M 0.16%
66,720
+200
+0.3% +$8.51K
DAL icon
109
Delta Air Lines
DAL
$60.5B
$2.79M 0.15%
48,290
-3,290
-6% -$181K
TFCFA
110
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$2.74M 0.15%
59,088
+1,750
+3% +$80.2K
APC
111
DELISTED
Anadarko Petroleum
APC
$2.71M 0.15%
+40,190
New +$2.71M
EA
112
DELISTED
Electronic Arts
EA
$2.69M 0.15%
22,350
+2,650
+13% +$342K
ZBH icon
113
Zimmer Biomet
ZBH
$18.5B
$2.69M 0.15%
21,082
+5,047
+31% +$600K
CMI icon
114
Cummins
CMI
$88.7B
$2.66M 0.15%
18,240
+4,733
+35% +$666K
SYF icon
115
Synchrony
SYF
$25.6B
$2.66M 0.15%
85,690
+23,450
+38% +$747K
APD icon
116
Air Products & Chemicals
APD
$66.8B
$2.58M 0.14%
15,437
-250
-2% -$40.7K
PH icon
117
Parker-Hannifin
PH
$135B
$2.56M 0.14%
13,920
+3,400
+32% +$584K
AMAT icon
118
Applied Materials
AMAT
$419B
$2.54M 0.14%
65,725
+5,000
+8% +$221K
LUV icon
119
Southwest Airlines
LUV
$23B
$2.53M 0.14%
40,535
-1,310
-3% -$76.6K
NTRS icon
120
Northern Trust
NTRS
$33.7B
$2.52M 0.14%
24,640
+7,800
+46% +$835K
ELV icon
121
Elevance Health
ELV
$84.9B
$2.5M 0.14%
+9,120
New +$2.37M
AMT icon
122
American Tower
AMT
$79.8B
$2.5M 0.14%
17,190
-25
-0.1% -$3.67K
AET
123
DELISTED
Aetna Inc
AET
$2.5M 0.14%
12,304
+50
+0.4% +$9.77K
CELG
124
DELISTED
Celgene Corp
CELG
$2.48M 0.14%
27,750
-14,575
-34% -$1.29M
STT icon
125
State Street
STT
$50.8B
$2.42M 0.13%
28,890
+14,690
+103% +$1.29M

Similar funds

Oakbrook Investments's Q3 2018 Portfolio in Review

As of Q3 2018, Oakbrook Investments held 698 positions worth $1.8B, up 14% from $1.58B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Oakbrook Investments deployed $92.2M of net new capital in Q3 2018, opening 144 new positions and adding to 374 existing holdings. Its largest new stake was Colgate-Palmolive: 345,909 shares worth $23.2M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $23.4M trimmed.

  • Oakbrook Investments's largest Q3 2018 buy was Colgate-Palmolive: 345,909 shares worth $23.2M.
  • Oakbrook Investments added most to Mondelez International in Q3 2018, an estimated $11.8M increase.
  • Oakbrook Investments's biggest Q3 2018 reduction was Gilead Sciences, cutting an estimated $23.4M.
  • Oakbrook Investments fully exited CSX Corp in Q3 2018, selling an estimated $3.83M.
  • Oakbrook Investments's ten largest holdings make up 23% of its $1.8B portfolio in Q3 2018.
  • Oakbrook Investments opened 144 new positions and closed 60 in Q3 2018.
  • Oakbrook Investments's portfolio value rose 14% quarter-over-quarter to $1.8B.

Based on Oakbrook Investments's 13F filing for Q3 2018, filed 18 Oct 2018.